News for Healthier Living

Bone-Building Drugs Restore Jawbone Lost to Type 2 Diabetes in Mice

Researchers report that two FDA-approved bone anabolic agents, parathyroid hormone (PTH) and abaloparatide (ABL), can restore alveolar bone lost to type 2 diabetes (T2D) in mice. Unlike in non-diabetic animals, where the drugs stimulated both bone formation and resorption with no net gain, in diabetic mice they selectively boosted bone formation without further increasing the already elevated resorption, producing net bone gain. The work identifies osteocytes as the cellular mediators of this anabolic effect and points to a strategy for improving tooth retention and dental implant success in diabetic patients.

November 11, 2026


November 11 2026

November 10 2026

November 9 2026

November 8 2026

November 7 2026

November 6 2026

November 5 2026

November 4 2026

November 3 2026

November 2 2026

November 1 2026

October 30 2026

October 29 2026